Literature DB >> 1269215

Kinetics of high-dose intravenous morphine in cardiac surgery patients.

D R Stanski, D J Greenblatt, D G Lappas, J Koch-Weser, E Lowenstein.   

Abstract

Ten patients received 1.0 mg/kg of morphine sulfate by constant-rate intravenous infusion at 5 mg/min over 9 to 27 min. Multiple arterial blood samples were drawn during the first 30 to 151 min after termination of the infusion, prior to institution of cardiopulmonary bypass. Postinfusion plasma concentrations were fitted by computer to biexponential functions consistent with a 2-compartment open pharmacokinetic model. Mean (+/- SE) pharmacokinetic parameters were: volume of central compartment, 0.09 +/- 0.03 L/kg; total apparent volume of distribution, 1.02 +/- 0.09 L/kg; distribution T 1/2, 0.90 +/- 0.09 min; apparent elimination T 1/2, 137 +/- 14 min; total clearance, 378 +/- 63 ml/min. Thus distribution of morphine is very rapid, but the apparent volume of distribution is only slightly larger than body weight, suggesting limited tissue uptake. Since apparent elimination T 1/2s are similar to those reported after smaller doses, evidence of saturable or capacity-linked elimination is lacking. Total clearances, representing mainly hepatic clearance, averaged about 25% of hepatic blood flow, suggesting clinically important first-pass metabolism of oral morphine.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 1269215     DOI: 10.1002/cpt1976196752

Source DB:  PubMed          Journal:  Clin Pharmacol Ther        ISSN: 0009-9236            Impact factor:   6.875


  11 in total

1.  Drug kinetics and artificial kidneys.

Authors:  T B Gibson; H A Nelson
Journal:  Clin Pharmacokinet       Date:  1977 Nov-Dec       Impact factor: 6.447

2.  Drastic improvement in the rectal absorption profile of morphine in man.

Authors:  F Moolenaar; J P Yska; J Visser; D K Meijer
Journal:  Eur J Clin Pharmacol       Date:  1985       Impact factor: 2.953

3.  Pharmacokinetics of nicomorphine and its metabolites in man after epidural administration.

Authors:  P M Koopman-Kimenai; T B Vree; M A Hasenbos; E W Weber; C P Verweij-Van Wissen; L H Booij
Journal:  Pharm Weekbl Sci       Date:  1991-06-21

4.  Patient-controlled analgesic therapy, Part IV: pharmacokinetics and analgesic plasma concentrations of morphine.

Authors:  B Dahlström; A Tamsen; L Paalzow; P Hartvig
Journal:  Clin Pharmacokinet       Date:  1982 May-Jun       Impact factor: 6.447

5.  Pharmacokinetics of intramuscular nicomorphine and its metabolites in man.

Authors:  P M Koopman-Kimenai; T B Vree; L H Booij; R Dirksen; G M Nijhuis
Journal:  Eur J Clin Pharmacol       Date:  1991       Impact factor: 2.953

Review 6.  High-dose morphine and methadone in cancer patients. Clinical pharmacokinetic considerations of oral treatment.

Authors:  J Säwe
Journal:  Clin Pharmacokinet       Date:  1986 Mar-Apr       Impact factor: 6.447

7.  Evaluation of the accuracy of a pharmacokinetically-based patient-controlled analgesia system.

Authors:  H Hill; A Mackie; B Coda; R Schaffer; R Jacobson; C Benedetti
Journal:  Eur J Clin Pharmacol       Date:  1992       Impact factor: 2.953

8.  The feasibility of physiologically based pharmacokinetic modeling in forensic medicine illustrated by the example of morphine.

Authors:  Nadine Schaefer; Daniel Moj; Thorsten Lehr; Peter H Schmidt; Frank Ramsthaler
Journal:  Int J Legal Med       Date:  2017-12-01       Impact factor: 2.686

9.  Kinetic disposition of morphine in young males after intravenous loading and maintenance infusions.

Authors:  D S Sitar; P C Duke; J A Owen; L Berger; P A Mitenko
Journal:  Can Anaesth Soc J       Date:  1986-03

10.  Potential pulmonary uptake and clearance of morphine in postoperative patients.

Authors:  M P Persson; L Wiklund; P Hartvig; L Paalzow
Journal:  Eur J Clin Pharmacol       Date:  1986       Impact factor: 2.953

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.